Submitted:
21 November 2025
Posted:
24 November 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results
Case 1
Case 2
Case 3
Case 4
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
| AUTHOR NAME | RESEARCH DESIGN | DATA ACQUISITION AND/OR RESEARCH EXECUTION | DATA ANALYSIS AND/OR INTERPRETATION | MANUSCRIPT PREPARATION |
| Abdullah Amini | ☐ | ☒ | ☒ | ☒ |
| Adam Besic | ☐ | ☐ | ☐ | ☒ |
| Avery Freund | ☐ | ☐ | ☐ | ☒ |
| Yousif Subhi | ☐ | ☐ | ☒ | ☒ |
| Oliver Niels Klefter | ☐ | ☐ | ☒ | ☒ |
| Jes Olesen | ☐ | ☐ | ☒ | ☒ |
| Jette Frederiksen | ☐ | ☐ | ☐ | ☒ |
| Michael Larsen | ☒ | ☒ | ☒ | ☒ |
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| BCVA | Best-corrected visual acuity |
| OCT | Optical coherence tomography |
References
- Sharpe, C.R. The visibility and fading of thin lines visualized by their controlled movement across the retina. J Physiol. 1972, 222, 113–134. [Google Scholar] [CrossRef] [PubMed]
- Tehovnik, E.J.; Slocum, W.M.; Carvey, C.E.; Schiller, P.H. Phosphene induction and the generation of saccadic eye movements by striate cortex. J Neurophysiol. 2005, 93, 1–19. [Google Scholar] [CrossRef] [PubMed]
- Nixon, T.R.W.; Davie, R.L.; Snead, M.P. Posterior vitreous detachment and retinal tear – a prospective study of community referrals. Eye. 2024, 38, 786–791. [Google Scholar] [CrossRef] [PubMed]
- Gishti, O.; van den Nieuwenhof, R.; Verhoekx, J.; van Overdam, K. Symptoms related to posterior vitreous detachment and the risk of developing retinal tears: a systematic review. Acta Ophthalmol. 2019, 97, 347–352. [Google Scholar] [CrossRef] [PubMed]
- Kanski, J.J. Complications of acute posterior vitreous detachment. Am J Ophthalmol. 1975, 80, 44–46. [Google Scholar] [CrossRef] [PubMed]
- Nüßle, S.; Reinhard, T.; Lübke, J. Acute closed-angle glaucoma. Dtsch Arztebl Int. 2021, 118, 771–780. [Google Scholar] [CrossRef] [PubMed]
- Thomsen, A.V.; Ashina, H.; Al-Khazali, H.M.; et al. Clinical features of migraine with aura: a REFORM study. J Headache Pain. 2024, 25, 22. [Google Scholar] [CrossRef] [PubMed]
- Viana, M.; Hougaard, A.; Tronvik, E.; et al. Visual migraine aura iconography: A multicentre, cross-sectional study of individuals with migraine with aura. Cephalalgia. 2024, 44, 1–10. [Google Scholar] [CrossRef] [PubMed]
- Olesen, J. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018, 38, 1–211. [Google Scholar] [CrossRef]
- Frohman, T.C.; Davis, S.L.; Beh, S.; Greenberg, B.M.; Remington, G.; Frohman, E.M. Uhthoff’s phenomena in MS--clinical features and pathophysiology. Nat Rev Neurol. 2013, 9, 535–540. [Google Scholar] [CrossRef] [PubMed]
- Schankin, C.J.; Viana, M.; Goadsby, P.J. Persistent and Repetitive Visual Disturbances in Migraine: A Review. Headache.Blackwell Publishing Inc. 2017, 57, 1–16. [Google Scholar] [CrossRef] [PubMed]
- Shah, D.R.; Dilwali, S.; Friedman, D.I. Current Aura Without Headache. Curr Pain Headache Rep. 2018, 22, 77. [Google Scholar] [CrossRef] [PubMed]
- Hadjikhani, N.; Sanchez Del Rio, M.; Wu, O.; et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 2001, 98, 4687. [Google Scholar] [CrossRef] [PubMed]
- Carroll, D. Retinal migraine. Headache: The Journal of Head and Face Pain. 1970, 10, 9–13. [Google Scholar] [CrossRef] [PubMed]
- Evans, I.D.; Palmisano, S.; Croft, R.J. Retinal and Cortical Contributions to Phosphenes During Transcranial Electrical Current Stimulation. Bioelectromagnetics. 2021, 42, 146–158. [Google Scholar] [CrossRef] [PubMed]
- Doyle, E.; Vote, B.J.; Cosswell, A.G. Retinal migraine: Caught in the act [2]. British Journal of Ophthalmology. 2004, 88, 301–302. [Google Scholar] [CrossRef] [PubMed]
- Hill, D.L.; Daroff, R.B.; Ducros, A.; Newman, N.J.; Biousse, V. Most Cases Labeled as “Retinal Migraine” Are Not Migraine. Journal of Neuro-Ophthalmology. 2007, 27, 3–8. [Google Scholar] [CrossRef] [PubMed]

| Patient 1 | Patient 2 | Patient 3 | Patient 4 | |
|---|---|---|---|---|
| Age, sex | 48 y, male | 52 y, female | 69, female | 46 y, male |
| Visual field location of flicker | Periphery of inferior quadrants, right eye | Upper visual field, waves in motion, mostly right eye, in left eye never after PDT for CSC | Left eye, straight ahead, | Inferior quadrants, right eye |
| BCVA OD/OS | 1.25/1.25 | 1.0/1.0 | 0.9/0.4 | 1.0/1.0 |
| Flicker rate [Hz] | 7 | 7 | 3 | 10 |
| Pattern | Oblique grating | Oblique ripples | Grating | Uniform patch |
| Visibility | Faint but distinct | Faint but distinct | Distinct | Faint but distinct |
| Transparency | High | High | High | High |
| Duration | Minutes | Minutes | Days | Minutes |
| Timing | Spontaneous, episodically, approx. 10 times per year | Spontaneous, up to hours | Left eye suddenly dark, after 1 hour, finger counting but no colors, after 2 days near-normal colors, no flicker | Spontaneously, during and after jogging, after lying down |
| Ambient luminosity | Dim nocturnal after awakening and standing | Dim nocturnal and sometimes in daylight | Any | Any |
| Stimulating factors | After waking from sleep and while exercising | After strenuous exercise and in dim light | During event with retinal vein occlusion | Onset of flicker while jogging and exacerbation of events during episodes of retinal venous congestion |
| Alleviating factors | Ambient light | Ambient light | Faded after regression of retinal vein occlusion. | Faded with spontaneous regression of venous congestion. |
|
Automated perimetry, OD/OS, mean deviation (-2,2) |
1.1 dB/-0,5 dB (normal) | 2.0 dB/4.0 dB (inferior to the fovea) | 7.2 dB/2.7 dB (nasal quadrants) | 3.4 dB/1.9 dB (irregular) |
| Medications | Metoprolol, losartan, apixaban, amlodipine | Dabigatran, formoterol | Pravastatin, levothyroxine, salbutamol, fluticasone | None |
| Past medical history | Atrial fibrillation, arterial hypertension, migraine with cortical and retinal visual aura | CSC OU with cessation of flicker OS after PDT, persisting OD. Pulmonary embolism. Occasional visual aura without migraine, non-scintillating, no flicker | Central retinal vein congestion with branch retinal artery hypoperfusion, cataract OU, hypercholesterolemia, hypothyroidism, asthma | CRVO OD, earlier Hemi-CRVO OS. Left side ophthalmic nerve herpes zoster, anterior uveitis |
| A. At least two attacks fulfilling criteria B and C B. One or more of the following fully reversible aura symptoms: 1. Visual. 2. Sensory. 3. speech and/or language. 4. Motor. 5. Brainstem. 6. Retinal. C. At least three of the following six characteristics: 1. at least one aura symptom spreads gradually over ≥5 minutes 2. two or more aura symptoms occur in succession 3. each individual aura symptom lasts 5–60 minutes 4. at least one aura symptom is unilateral 5. at least one aura symptom is positive (scintillations or pins and needles**) 6. the aura is accompanied, or followed within 60 minutes, by headache D. Not better accounted for by another ICHD-3 diagnosis and transitory ischemic attack have been excluded --------------------------------------------------------------------------------------------------------------------- *) unilateral means on one side of the midline of the body or the midline of the binocular visual field **) pins and needles refer to sensation of a type of pain without any specific relation to the eye or vision |
| Description: Repeated attacks of monocular visual disturbance, including scintillations, scotomata or blindness, associated with migraine headache. Diagnostic criteria: A. Attacks fulfilling criteria for migraine with aura (see above) and criterion B below: B. Aura characterized by both of the following: 1. fully reversible, monocular, positive and/or negative visual phenomena (e.g., scintillations, scotomata or blindness) confirmed during an attack by either or both of the following: a. clinical visual field examination b. the patient’s drawing of a monocular field defect (made after clear instruction) 2. at least two of the following: a. spreading gradually over ≥5 minutes b. symptoms last 5–60 minutes c. accompanied or followed within 60 minutes by headache C. not better accounted for by another ICHD-3 diagnosis and other causes of amaurosis fugax have been excluded. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).